Income Statement

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues:    
Grants $ 0 $ 148,054
Total revenues 0 148,054
Operating costs and expenses:    
Research and development 7,544,122 7,800,723
General and administrative 10,526,340 9,010,450
Total operating costs and expenses 18,070,462 16,811,173
Loss from operations (18,070,462) (16,663,119)
Interest and other expenses, net of income (950,217) (997,364)
Net loss (19,020,679) (17,660,483)
Deemed dividend on May 2017 inducement shares (5,220,000) 0
Deemed dividend on August 2017 inducement shares (3,120,000) 0
Deemed dividend on warrant repricing (19,413) 0
Deemed dividend on preferred stock exchange (5,411,284) 0
Net loss allocable to common stockholders $ (32,791,376) $ (17,660,483)
Basic and diluted net loss per share $ (8.56) $ (10.91)
Shares used to calculate basic and diluted net loss per share 3,830,162 1,619,251

Source